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Covalent protein-nucleic acid conjugates form an original class of compounds that occur in
nature or can be generated in vitro through cross-linking to investigate domains involved in
protein/nucleic acid interactions. Their mass spectrometry fragmentation patterns are poorly
characterized. We have used electrospray-ionization mass spectrometry (ESI-MS) combined
with collision-induced dissociation (CID) to characterize microcin C7-C51, an antimicrobial
nucleotide peptide that targets aspartyl-tRNA synthetase and inhibits translation. The frag-
ments of microcin C7-C51 were analyzed in positive- and negative-ion modes and compared
with those of the corresponding unmodified heptapeptide and to the derived aspartyl-
adenylate. The positive- and negative-ion mode fragments of microcin C7-C51 provided
information on both the nucleotide and peptide moieties. Accurate mass measurement
obtained using an LTQ Orbitrap instrument was a key factor for a comprehensive interpre-
tation of the fragments. The experimental results obtained permitted the proposal of stepwise
fragmentation pathways involving ion– dipole complexes. The data provide a better under-
standing of nucleotide peptide fragmentation in the gas phase. (J Am Soc Mass Spectrom
2008, 19, 1187–1198) © 2008 American Society for Mass SpectrometryFundamental processes of gene regulation by reg-ulatory proteins depend on the recognition ofnucleic acid structures or base sequences. Interac-
tions between nucleic acids and peptides/proteins can
result in covalent complexes that either act as architec-
tural components of the cell, or lead to up- or down-
regulation of a specific gene through activation [1].
Cross-linked peptide or protein-nucleic acid conjugates
have been described in RNA and DNA viruses, in DNA
topoisomerases, or as amino acid-RNA conjugates in
aminoacyl-tRNAs [2]. Furthermore, UV-induced cross-
linking has emerged as an efficient method to charac-
terize RNA interactions with peptides/proteins, in par-
ticular within ribonucleoprotein particles [3, 4].
Electrospray-ionization (ESI) is an energetically soft
ionization process and has become the standard
method to characterize a large variety of biomolecules.
While much of the early work concerns peptides and
proteins, there has been an increasing number of stud-
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doi:10.1016/j.jasms.2008.04.020ies that have demonstrated the excellent potential of
ESI-MS for the characterization of nucleotides [5].
Collision-induced dissociation (CID) is now used rou-
tinely to sequence protonated peptides [6]. Fragmenta-
tions of deprotonated peptides formed in the negative-
ion mode are currently less used for sequencing
purposes [7, 8]. Furthermore, CID experiments have
allowed the characterization of diagnostic product ions
of protonated and deprotonated nucleotides and nucle-
otide derivatives [9, 10]. However, the gas-phase frag-
mentations of nucleotide peptides have merely been in-
vestigated. I n t h e 1970s, odd-electron species formed by
electron ionization were shown to be able to isomerize
into ion– dipole complexes before dissociation. This
potential was demonstrated by Bowen et al. [11] for
small molecules and by Longevialle et al. for steroids
[12]. More recently, this concept has been applied to
positively-charged [13] and negatively-charged [14, 15]
even-electron molecular systems and in particular to
peptide dissociations [15]. Formation of ion-neutral as
intermediates has been shown to imply a charge-
promoted cleavage process that can be accompanied by
a proton transfer on both partners of the complex,
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basicity/acidity).
Microcins form a peculiar class of gene-encoded
low-molecular-weight antibacterial peptides secreted
by Enterobacteria [16]. Microcin C7-C51 (MccC7-C51) is
the smallest microcin isolated to date (Scheme 1a). It is
a ribosomally-synthesized N-formylated heptapeptide
including a C-terminal aspartic acid, which is covalently
linked to a phosphoramidate group, itself substituted
with both an adenosine moiety and a propylamine
chain [17]. MccC7-C51 activity involves an original
mechanism of “Trojan horse” type [18, 19], where the
microcin is allowed to enter, freely target bacteria, and
is transformed when inside into a toxic entity. Indeed, a
specific cleavage occurs inside the target bacteria at the
microcin Ala6–Asp7 peptide bond that yields a modi-
fied aspartyl-adenylate named MccC7-C51* (Scheme
1b). This entity, which is the actual intracellularly active
form of the microcin, is an inhibitor of translation [18].
It can be generated in vitro by specific enzymatic
cleavage [18]. MccC7-C51, which is composed of two
distinct parts, a peptidic moiety (the heptapeptide that
we term PepC7-C51) (Scheme 1c) and a modified nu-
cleotide moiety connected through a phosphoramidate
bond, thus offering a unique opportunity to study the
fragmentation of nucleotide peptides. Indeed, the pep-
tide and nucleotide parts can be analyzed either inde-
pendently, using the heptapeptide PepC7-C51 and the
modified nucleotide MccC7-C51*, or associated in the
native MccC7-C51.
Here, we report the characterization of the nucleo-
tide peptide MccC7-C51, of the corresponding unmod-
ified heptapeptide PepC7-C51, and of the derived trans-
lation inhibitor MccC7-C51* by ESI-MS, to afford keys
to nucleotide peptide structural elucidation. Fragmen-
tation patterns were analyzed in both the positive- and
negative-ion modes. To demonstrate the fragmentation
mechanisms proposed, experiments were performed
using the recently-introduced high-resolution LTQ Or-
bitrap instrument, which consists of a hybrid linearSchemequadrupole ion trap (LTQ) coupled to the novel Fourier-
transform (FT) analyzer Orbitrap [20–24]. Finally, differ-
ent mechanistic aspects that drive the fragmentations are
proposed through the formation of ion–dipole complexes.
In particular, the occurrence of zwitterionic-like species,
which strongly influence the orientation of the fragmen-
tations promoted by the charge, is discussed [25].
Experimental
Materials
The formylated peptide f-MRTGNAD-NH2 (PepC7-
C51) was obtained from Genepep (Montpellier, France)
purity  95% checked by high-performance liquid chro-
matography (HPLC) and mass spectrometry.
Production and Purification of MccC7-C51 and
MccC7-C51*
The E. coli strain TG1 harboring the MccC7-C51 plasmid
pBM43 was grown for 18 h at 37 °C in M63 minimum
medium. The cells were removed by centrifugation (20
min at 10,000 g) and the supernatant was loaded onto a
C18 solid-phase extraction cartridge (SepPak; Waters
Corp., Saint Quentin en Yvelines, France), conditioned
withMeOH and equilibratedwith 0.1% aqueous trifluoro-
acetic acid (TFA). The cartridge was washed with 0.1%
aqueous TFA and the elution was performed stepwise
with 5%, 10%, 15%, and 20%MeOH in 0.1% aqueous TFA.
The 15%MeOH fraction was dried under vacuum, recon-
stituted in water, and subjected to reversed-phase high-
performance liquid chromatography (RP-HPLC) on a C18
column (Capcell 5 m, 4.6  250 mm; Interchim,
Montluçon, France) using a 0% to 15% linear gradient of
acetonitrile in 0.1% TFA at a flow rate of 1 mL/min.
Absorbance was monitored at a  of 226 nm and the
microcin fraction was collected manually.
To obtain MccC7-C51*, MccC7-C51 was incubated
for 2 h in 10 mM ammonium acetate buffer, pH 6.5, in1
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substrate ratio of 1/200 (wt/wt). The reaction mixture
was subjected to RP-HPLC on a C18 column (Capcell 5
m, 4.6  250 mm; Interchim) using a 0% to 25% linear
gradient of acetonitrile in 0.1% TFA at a flow rate of 1
mL/min. Absorbance was monitored at a  of 226 nm
and the MccC7-C51* fraction was collected manually.
Mass Spectrometry
MccC7-C51, MccC7-C51* and PepC7-C51 samples were
analyzed at concentrations of 10 or 100 pmol/L in 10
mM ammonium acetate buffer pH 6.5. The ESI-MS
analyses were carried out on a Qq-TOF/MS instrument
(Q-Star Pulsar; Applied Biosystems, Courtaboeuf,
France) and a LTQ Orbitrap instrument [19–23] (Thermo
Electron, les Ulis, France) operated in positive- and nega-
tive-ion modes. The Qq-TOF instrument was equipped
with a nanospray source and operated with capillary
voltage values between 800 and 1100 V. When appropri-
ate, the declustering potential was optimized to favor
the formation of m/z 445 and 630 product ions by “in
source CID processes” from the nanoESI experiments.
For CID experiments of selected ions in the Qq-TOF
analyzer, the collision energy varied between 5 and 50
V. Accurate mass measurements were performed on the
LTQ Orbitrap instrument. MccC7-C51 or PepC7-C51
solutions were introduced into the ESI source at a flow
rate of 5 L/min and the instrument was operated in
positive- and negative-ion modes with a spray voltage
of 3 kV. When necessary, the tube lens voltage was
optimized to favor in source-fragmentations resulting
in them/z 445 and 630 product ions. Them/z 212 and 214
ions were used as internal lock mass calibrants in
negative- and positive-ion modes, respectively. For CID
experiments in the LTQ cell, the standard technique for
ion fragmentation by resonant excitation was used. The
amplitude voltage of the axial excitation was standard-
ized by using normalized collision energy (NCE) in-
creasing from 15% to 60% [22]. A mass accuracy of 2
ppm and 10 ppm was observed on the LTQ Orbitrap
and on the Qq-TOF/MS instruments, respectively.
Results and Discussion
Positive Ions Generated from MccC7-C51, MccC7-
C51*, and PepC7-C51 in the ESI Source with Low
Collision Energy
Positive ions generated under ESI conditions. A compar-
ative analysis of the ESI spectra of MccC7-C51, MccC7-
C51*, and PepC7-C51 was performed on the ESI-Qq-TOF.
The detected ions and their corresponding relative abun-
dances are summarized in Table 1. Under the ESI condi-
tions used, the positive-ion mode ESI mass spectrum of
MccC7-C51 displayed [Mc 2H]2 as base peak, together
with the corresponding cationized [(McH)Na]2and
the minor triply protonated [Mc 3H]3 species. Further-
more, a product ion assigned to the protonated peptide(m/z 791), resulting from the “in-source” release of the
modified nucleotide moiety, was also observed in low
abundance (Table 1a). By contrast, the ESI mass spectrum
of MccC7-C51* only displayed the monoprotonated
[Mc*H] as base peak, accompanied by several cation-
ized species, [Mc*Na], [(Mc*H) 2Na] and [(Mc*
 2H)  3Na]. “In-source” product ions were not
detected: this may be due to the absence of the doubly
charged [Mc*  2H]2 species, which is less stable than
the singly charged one. The ESI-mass spectrum of PepC7-
C51 displayed a similar trend to that of MccC7-C51, with
the doubly protonated [Mp 2H]2 as base peak, as well
as the corresponding cationized [(Mp  H)  Na]2
species. The monoprotonated [Mp  H] and the cation-
Table 1. Main ions displayed on the ESI mass spectra of
MccC7-C51, PepC7-C51, MccC7-C51* in positive (a) and
negative (b) ion modes
Compounds m/z and relative intensities (% of base peak)
(a)
MccC7-C51 Molecular species
[Mc  H] m/z 1177.4 (1)
[Mc  2H]2 m/z 589.2 (base peak);
[(Mc  H)  Na]2 m/z 600.2 (15)
[Mc  3H]3 m/z 393.2 (6); [(Mc  2H) 
Na]3 m/z 400.2 (1)
“In-source” product ions
m/z 791.3 (1)a
MccC7-C51* Molecular species
[Mc*  H]  m/z 519.2 (base peak);
[Mc*  Na] m/z 541.1 (97)
[(Mc* – H)  2Na] m/z 563.1 (45)
[(Mc* – 2H)  3Na] m/z 585.1 (16)
PepC7-C51 Molecular species
[Mp  H] m/z 791.3 (7); [Mp  Na] m/z
813.3 (1)
[Mp  2H]2 m/z 396.2 (base peak);
[(Mp  H)  Na]2 m/z 407.2 (27)
[Mp  2Na]2 m/z 418.2 (5)
“In-source” product ions
m/z 316.1 (4)a; m/z 459.2 (2)a; m/z 476.2 (1)a
m/z 588.3 (2)a; m/z 659.3 (4)a
[(Mp  2H) – NH3]
2 m/z 387.7 (30)
(b)
MccC7-C51 Molecular species
[Mc – H] m/z 1175.5 (1)
[Mc – 2H]2 m/z 587.2 (base peak);
[(Mc – 3H)  Na]2 m/z 598.2 (10)
“In-source” product ions
m/z 789.3 (1)a
MccC7-C51* Molecular species
[Mc* – H] m/z 517.2 (base peak);
[(Mc* - 2H)  Na] m/z 539.2 (27)
“In-source” product ions
m/z 402.2 (10)a
PepC7-C51 Molecular species
[Mp – H] m/z 789.3 (27)
[Mp – 2H]2 m/z 394.1 (63)
“In-source” product ions
m/z 363.1 (1)a; m/z 445.2 (2)a
[(Mp – 2H) - 44]2 m/z 372.1 (base peak)
aSingly-charged product ions.ized [Mp  Na] and [Mp  2Na]2 species were also
c 
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charged [(Mp 2H)NH3]
2 product ion, which results
from a prompt “in-source” NH3 loss, was observed. The
occurrence of such an unusual NH3 loss suggests that the
positive charge was located at the C-terminal side of the
peptide, given that the N-terminus is formylated. Several
low-abundance diagnostic ions were also detected at m/z
316, 459, 476, 588, and 659 (Table 1a), which also resulted
from “in-source” peptide fragmentation.
To get a comprehensive view of the gas-phase frag-
mentations of nucleotide peptides and nucleotide moi-
eties compared with those of the corresponding un-
modified peptides, low-energy CID processes were
conducted on the molecular species arising from
MccC7-C51, MccC7-C51*, and PepC7-C51 (Figure 1,
Figure 2, and Figure 3).
Product Ions Generated Under Low Collision Energy from
Protonated Species. CID experiments were carried out
on the three MccC7-C51 molecular species, [Mc  H]
(m/z 1177), [Mc  2H]2 (m/z 589) (Figure 1) and [Mc 
3H]3 (m/z 393) (data not shown). The major product
ions (m/z 791, 773, and 250) of the CID spectra were
formed from the two precursor ions [McH] and [Mc
 2H]2, together with other weaker product ions at
m/z 1120, 1042 and 871. The m/z 560 and 521 product
ions displayed in the CID spectrum of [Mc  2H]2,
were assigned to the doubly charged species corre-
sponding to the singly charged species at m/z 1120 and
1042, respectively. Finally, the product ion at m/z 136
was observed with a high abundance from the [Mc 
2H]2 precursor ion, and with a weaker abundance
Figure 1. Positive-ion mode CID spectra of Mc
mM ammonium acetate buffer pH 6.5 recorded o
H] at m/z 1177, Ec  50 eV. (b) Selection of [Mfrom the [Mc  H] precursor ion. Indeed, the essentialdifference between the product ion spectra of the sin-
gly- and doubly charged MccC7-C51 species was the
presence of the m/z 252 ion, arising from dissociation of
[Mc  2H]2 and not from [Mc  H]. In addition, the
singly charged m/z 97 and m/z 58 product ions dis-
played in the CID spectrum of [Mc  2H]2 were
detected with a weak abundance from the [Mc  H]
precursor ion, while the m/z 234 product ion was only
observed in the CID spectrum of [Mc  2H]2. Taking
into account these whole results, we propose a series of
decomposition pathways of MccC7-C51, considering
that several peaks can be associated (1) by pairs of
product ions (noted |m/z xxx //m/z yyy|), that are
C51 obtained from 100 pmol/L solution in 10
ESI-Qq-TOF instrument. (a) Selection of [Mc 
2H]2 at m/z 589, Ec  80 eV.
Figure 2. Positive-ion mode CID spectrum of MccC7-C51* ([Mc*
 H] at m/z 519) obtained from 100 pmol/L solution in 10 mM
ammonium acetate buffer pH 6.5 recorded on the ESI-Qq-TOFcC7-
n theinstrument (Ec  30 eV).
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(e.g., [Mc  2H]2), or (2) by ion–dipole complexes
(noted {m/z xxx/yyy u}) that result from isomerization
of the singly charged ion before consecutive dissocia-
tions. These non covalent species can either directly
dissociate or yield complementary ions via internal
proton transfer. Thus, three pairs of complementary
product ions due to charge separation processes can be
formed from the [Mc  2H]2 precursor ion (m/z 589):
|m/z 1042 // m/z 136|, |m/z 791//m/z 387| and |m/z
1120//m/z 58|), which define three stepwise dissocia-
tion pathways noted a, b, and c (Scheme 2):
1. In the a pathway, the m/z 1042 product ion may
isomerize via the a2 process into the A2 ion–dipole
before dissociation (vide infra). This occurs from
phosphate cleavage assisted by a nucleophilic attack
of the propylamine side chain NH2 group followed
by proton transfer to the peptide to give rise to the
formation of the m/z 791 ion, corresponding to the
protonated heptapeptide. From the A2 ion–dipole,
internal proton transfer from the peptide to the
modified phosphate group yields the m/z 252 prod-
uct ion of second generation. After A2= ion–dipole
dissociation, the m/z 252 product ion is able to
undergo the consecutive release of (1) a water
molecule (a3 step) and (2) the O  P[O(CH2)3N]
modified phosphate group (a4 step), to yield the m/z
234 and 97 (a protonated furane-2-aldehyde) ions.
These consecutive dissociations of m/z 1042 explain
the low abundance of this ion compared with its
Figure 3. Positive-ion mode CID spectrum of Pe
pmol/L solution in 10 mM ammonium acetate b
(Ec  40 eV).complementary product ion at m/z 136.2. In the b pathway, the first step b1 consists of charge
parting yielding the m/z 387 and the complementary
m/z 791 product ions. The former can consecutively
isomerize through a proton transfer to the adeno-
sine moiety into the B2 ion–dipole via the b2 pro-
cess, before dissociating and either directly yield
the m/z 252 ion, or lead to protonated adenosine
(m/z 136), after reversible internal proton transfer
(B 2^B 2
′ , isomerization).
3. A similar stepwise process describes the c pathway,
for which the first cleavage step c1 occurs by charge
repulsion to yield the complementary m/z 58 and
1120 product ions. The latter is observed with a very
weak abundance, which is explained by considering
its possible isomerization (c2 step) into the C2 ion–
dipole, yielding either directly the m/z 250 product
ion (protonated dehydrated adenosine) or after in-
ternal proton transfer, the m/z 871 product ion (C2=
ion–dipole). Dephosphorylation of the m/z 871 spe-
cies from the C2= ion-neutral complex generates the
protonated heptapeptide (m/z 791) via the c3 pro-
cess. The latter, independently of its origin (i.e., a2,
b1, c3 processes) can lose a water molecule to yield
the m/z 773 product ion. Note that it cannot be ruled
out that the m/z 250 product ion may also arise from
the m/z 387 ion (b2 step). The former can yield
directly the m/z 136 product ion (c2step).
The dissociation pathways of the singly charged [Mc 
H] species (m/z 1177) occur via similar stepwise pro-
cesses (noted a, b, and c) to those of the doubly charged
C51 ([Mp 2H]2 atm/z 396) obtained from 100
pH 6.5 recorded on the ESI-Qq-TOF instrumentpC7-
uffer[Mc  2H]2 ion, the main difference being due to the
heme
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directly the isomerized A1, B1, and C1 ion–dipole com-
plexes (Scheme 3). The CID spectrum of [Mc  H]
appears less complex than that of [Mc  2H]2, due to
ScSchemethe decreased number of consecutive dissociation pro-
cesses. The main species detected are the m/z 791 and
250 (base peak) product ions (Figure 1a). The former
dissociates into m/z 773 by water release. The CID
23
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be rationalized similarly, by considering the formation
of pairs of product ions and isomerizations into ion–
dipole complexes (data not shown). Interestingly, the
m/z 250 and 252 product ions are observed in competi-
tion on the CID spectra of MccC7-C51, depending on
the charge carried by the precursor ions. The product
ion at m/z 250 is observed in the CID spectrum of [Mc
2H]2 (Figure 1b), together with the competing product
ion at m/z 252. However, of these two ions, only m/z 252
is detected on the CID spectrum of [Mc  3H]3, while
only m/z 250 is detected in the CID spectrum of [Mc 
H]. Thus, the m/z 252 ion appears to be favored when
the charge state of the precursor ion increases, which
reflects the role of the charge on dissociation processes
involving charge repulsion. Thus, both the charge loca-
tion (either at the peptide C-terminus, or next to the
phosphate group, or at the nucleoside group) and
distribution govern the orientation of product ion pair
formation through proton migration processes.
Similarly, the fragmentation pattern of the modified
aspartyl-adenylate MccC7-C51* strongly relies on the
location of the positive charge (Figure 2). The charge
appears to be located either at the amino group of the
aspartic acid residue, or of the propylamine chain, or at
the nucleotide moiety. As for MccC7-C51, several prod-
uct ions can be produced from the singly charged [Mc*
 H] precursor ion via stepwise processes through
isomerization into ion–dipole complexes: ({m/z 136/383
u}, {m/z 58/461 u}) (Scheme 4). Three competing frag-
mentation pathways are thus proposed for MccC7-
C51*:Scheme1. The a1 step yields the {m/z 136 / 383 u} A1 ion–
dipole. The aspartic acid release from the m/z 384
product ion leads consecutively to the m/z 252
product ion (a2 step). As for the microcin, the latter
generates the m/z 234 (a3 step) and consecutively the
m/z 97 (a4 step) product ions. The m/z 384 product
ion is able to undergo dissociation, yielding the A5
ion–dipole (i.e., {m/z 58/326 u}) via the a5 process.
2. In the b pathway, the m/z 387 product ion can
isomerize into the B2 ion–dipole complex through
the nucleobase release to yield the m/z 252 species
(b2 step).
3. In the c pathway, a similar isomerization generates
the C1 ion–dipole complex constituted by the pro-
tonated propenylamine and aspartic-AMP neutral
(c1 step), and subsequent isomerization by internal
proton transfer yields the m/z 462 ion. The latter
yields the protonated adenosine monophosphate at
m/z 348 (c4 step) through aspartic acid cyclization
and release. The m/z 348 ion can consecutively lose
the phosphate group (c6 step) to yield the m/z 268
ion as protonated adenosine. The latter can consec-
utively lose a water molecule and the ribose group,
to yield m/z 250 (protonated dehydrated adenosine)
as base peak (c7 step) and m/z 136 (c2 step), respec-
tively. The m/z 462 ion can also generate the C5
ion–dipole ({m/z 136/326 u}) and after proton trans-
fer, the C5= ion–dipole. As previously noticed for
MccC7-C51, the m/z 250 and 252 product ions are
formed in competition, depending upon the charge
state of the selected precursor ions (data not
shown). The results obtained with protonated4
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even-electron complex systems, the isomerization
into ion–dipole complexes takes place before dis-
sociation. This behavior is well known for a large
class of chemical compounds including organic
and biological molecules, such as certain amino
steroids [12], glycoconjugates [14], steroid fatty
acids [26], DNA adduct steroids [13], lipopolysac-
charides [27], and peptides [28]. If the complex life
time is sufficiently large, due to the relative low
internal energy compared to the dissociation en-
ergy threshold, internal proton transfer can occur,
resulting from the formation of complementary
ion pairs. Note that such isomerizations at the first
step of the fragmentation pathways, yielding ion-
neutral complexes, can be generalized to rational-
ize the fragmentation patterns of certain protein-
RNA cross-links analyzed by post-source decay
(PSD) experiments [3, 4].
The fragmentation pattern of PepC7-C51 was investi-
gated to interpret certain fragmentation mechanisms
observed for protonated MccC7-C51. The CID spectrum
of the doubly protonated PepC7-C51 ([Mp 2H]2, m/z
396) (Figure 3) resulted in a b-type ion series (m/z 160,
294, 316, 330, 378, 387, 417, 474, 588, and 659), a-type
ions at m/z 307, 356, and 631, and a weak c-type ion at
m/z 491. Furthermore, y-type ions at m/z 133 and 204
and two unexpected z-type ion at m/z 187 and 459 were
observed [29, 30]. Note that when the skimmer poten-
tial was increased, the b2
 ion at m/z 316 became the
dominant product ion (data not shown). The unmod-
ified peptide PepC7-C51 contains a basic residue at
the N-terminal side (Arg), which is susceptible to
retain the charge in this region, thus favoring a and b
product ions [31]. This is consistent with the fragmen-
tation pattern observed, with a majority of b-type
ions. However, once the protonated peptide has been
desorbed into the gas phase, proton transfer to the
carbonyl oxygen, the backbone amide nitrogen at-
oms, or to certain side-chain functional groups be-
comes possible, particularly upon collisional activa-
tion [32]. The presence of the complementary z and c
product ions, which are normally observed at high
collision energy, show that PepC7-C51 is prone to
undergo fragmentation, as illustrated by its tendency
to produce diagnostic ions “in source”.
From the whole data provided by the CID spectra,
the fragmentation of MccC7-C51 in positive ion mode
seems to result in two different sorts of product ions: a
class containing the peptide moiety and another one
consisting of nucleotide derivatives. Few peptide diag-
nostic ions are observed, while a loss of PepC7-C51,
adenine, and/or the propylamine chain are favored.
Therefore, the study of MccC7-C51 in positive-ion mode
provides mostly information on the nucleotide part of
the molecule.Negative Ions Generated in the ESI Source and
Under Low Collision Energy for MccC7-C51,
MccC7-C51*, and PepC7-C51
Negative ions generated under ESI conditions. The mass
spectrum of MccC7-C51 in negative-ion mode dis-
played a trend similar to that observed in positive-ion
mode. The doubly charged [Mc 2H]2 and the [(Mc
3H)  Na]2 molecular species were the major ions
detected (Table 1b). The negative-ion ESI-mass spec-
trum of MccC7-C51* displayed both the [Mc*  H]
(base peak) and [(Mc*  2H)  Na] species. Note that
a product ion at m/z 402 was observed, which corre-
sponded to a loss of aspartic acid from MccC7-C51*
(Table 1b).
The ESI-mass spectrum of PepC7-C51 showed
mainly the doubly deprotonated [Mp  2H]2- and [Mp
 H] species, together with minor product ions at m/z
363 and 445. Interestingly, an unexpected base peak was
detected at m/z 372, which corresponded to a loss of
44 u from the [Mp  2H]2 species. Such a 44-u neutral
loss is generally attributed to a CO2 release [33]. How-
ever, high resolution analysis of the m/z 372 ion, using
the LTQ Orbitrap instrument, permitted to assign un-
ambiguously this neutral loss to an elemental composi-
tion of C2H4O, corresponding to the release of CH3CHO
from the threonine side chain. Such a result, discussed
below in the CID data section, was previously reported
by Steinborner and Bowie. [33]. Note that this neutral
loss takes place exclusively from the doubly deproto-
nated peptide and not from the deprotonated [Mp 
H] species. To explain this difference in behavior, two
possible situations can be considered during the desol-
vation of charged aggregates at the skimmer. The first
way assumes that the C2H4O release takes place “in
source” before the aggregate ion desolvation, to yield
the solvated [(Mp  xs  2H)  44]2 product ion (xs
corresponds to x molecules of solvent). If this way
would operate, observation of both the [(Mp  2H) 
44]2 and [(Mp  H)  44] product ions should be
possible after solvent release as xs and [xs  H],
respectively. This pathway must be ruled out because of
the specific 44-u loss from the [Mp 2H]2 species. The
second possibility is to assume that the loss of C2H4O
takes place exclusively after total desolvation of the
doubly charged aggregate into [Mp  2H]2. Finally, it
is worth noting that for both the MccC7-C51 and the
MccC7-C51* molecules, the CH3CHO loss did not occur
from “in source dissociation”.
Product ions generated under low collision energy from
deprotonated species. CID experiments of MccC7-C51
were conducted on the molecular [Mc  H] (m/z 1175)
and [Mc  2H]2 (m/z 587.2) species (Figure 4). Note
that two common product ions at m/z 445 and 630 were
observed from these two precursor ions. In addition,
the CID spectrum of [Mc  H] displayed the m/z 772
ion corresponding to the b7
 product ion as base peak,
and a c6
 diagnostic ion at m/z 674 (Figure 4a). The loss
]2- at
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directly from [Mc  H] in accordance with the “in
source” behavior of PepC7-C51. The CID spectrum of
the doubly deprotonated [Mc  2H]2- species (Figure
4b), exhibited the product ion at m/z 134 as base peak,
which corresponds to the deprotonated adenine spe-
cies. As observed “in source” for PepC7-C51, a loss of
44 u (CH3CHO as confirmed by accurate mass measure-
ments) occurred from the [Mc  2H]2 precursor ion,
leading to the m/z 565 product ion. Several diagnostic
ions were also observed at m/z 184, 314, and 336, which
correspond to [y2  H2O]
, y6
2, and c6
2, respectively.
The doubly deprotonated MccC7-C51 species also
yielded the m/z 402 and 153 product ions, which were
attributed to the peptide release and both the peptide
and modified nucleotide releases, respectively.
The CID spectrum of the modified aspartyl-adeny-
late [Mc*  H] species, is shown in Figure 5. The
fragmentation pattern was rationalized by taking into
account the formation of ion–dipole complexes (Scheme
5), as previously done for the positive-ion mode. In
addition to the direct propylamine release (d path-
way) followed by the nucleoside loss (m/z 175), two
ion–dipole complexes A1 and E1 ({m/z 134/383 u} and
{m/z 114 / 403 u}) are formed from the precursor [Mc*
 H] ion, according to the two distinct a and e
Figure 4. Negative-ion mode CID spectra of M
mM ammonium acetate buffer pH 6.5 on the ES
m/z 1175, Ec  50 eV. (b) Selection of [Mc  2Hpathways:1. The a pathway, which yields the A1 ion–dipole,
involves a rearrangement around the phosphate
group from the m/z 382 ion, leading to the m/z 250
product ion and after internal proton transfer, the
m/z 131 ion (A2 ion–dipole) through the a2= process.
These consecutive dissociations of m/z 382 explain
the low abundance of this ion compared to its
complementary m/z 134 product ion.
-C51 obtained from 100 pmol/L solution in 10
-TOF instrument. (a) Selection of [Mc  H] at
m/z 587, Ec  50 eV.
Figure 5. Negative-ion mode CID spectrum of MccC7-C51*
([Mc*H] atm/z 517) obtained from 100 pmol/L solution in 10
mM ammonium acetate buffer pH 6.5 recorded on the ESI-Qq-ccC7
I-QqTOF instrument (Ec  35 eV).
heme
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403 u}) through the first step e1. The m/z 402 ion,
which results from aspartic acid release from the
precursor ion, appears as the base peak. The adenine
release from the m/z 402 product ion yields the E2
ion–dipole {m/z 134/268 u} (e2 step). The m/z 267 ion
can directly lose the ribose group, leading to the m/z
153 product ion (e3 step).
The CID spectrum of the deprotonated PepC7-C51
([Mp  H], m/z 789) (Figure 6) showed a base peak
corresponding to the m/z 445 product ion, together with
Sc
Figure 6. Negative-ion mode CID spectrum of PepC7-C51
([Mp  H] at m/z 789) obtained from 100 pmol/L solution in 10
mM ammonium acetate buffer pH 6.5 recorded on the ESI-Qq-
TOF instrument (Ec  45 eV).several diagnostic ions at m/z 114, 184, and 299, which
were assigned to the [y1–NH3]
, [y2–H2O]
, and [y3–
NH3]
 product ions. Those were due to a side-chain
cleavage of the aspartic acid and asparagine residues
[16]. A loss of 44 u from [Mp  H], leading to the m/z
745 ion was also observed. Two weak product ions at
m/z 403 and m/z 630 were detected. The former corre-
sponds to a loss of 42 u from the m/z 445 product ion
which can be attributed to a NHCNH release from
the arginine side chain. This assignment was confirmed
by using the LTQ Orbitrap instrument.
Finally, the m/z 445 and 630 product ions were
detected on the CID spectra of both the deprotonated
MccC7-C51 and PepC7-C51 molecules. This indicates
that these species encompass the peptide part and result
from peptide backbone cleavage. To characterize the
structure of the m/z 445 and 630 product ions, pseudo-
MS3 and MS3 experiments were performed on both the
Qq-TOF and the LTQ Orbitrap instruments. Fragmen-
tation of the selected ion at m/z 630 triggered the
formation of the m/z 445 ion exclusively. The CID
spectrum of the m/z 445 ion (data not shown) displayed
three major product ions at m/z 417, 403, and 375.
Formation of these three ions corresponds to a loss of
CO from the formyl group, a loss of NHCNH from
the arginine residue side chain and consecutive losses
of the CO and NHCNH groups, respectively. Fi-
nally, an additional analysis of the m/z 445 and 630 ions
with the LTQ Orbitrap instrument showed that these
two ions corresponded to the c4
 and c6
 diagnostic ions,
respectively, both of which underwent a loss of 44 u. As
discussed previously, this loss resulted from the cleav-
age of the threonine side chain, as observed upon
5“in-source” fragmentations of PepC7-C51 (Figure 6).
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CH3CHO rather than of CO2 is proposed to result from
the formation of a salt bridge. To produce such an
electrostatic interaction, zwitterionic forms must be
considered. They may occur between the deprotonated
aspartate and the protonated amino group of the pro-
pylamine chain in the case of MccC7-C51 and between
the same aspartate deprotonated site and the proton-
ated amino group at the C-terminus for PepC7-C51
(Scheme 6). In agreement with the proposed zwitteri-
onic structures involving salt bridges, and as expected
given the absence of the threonine residue, the CID of
the singly charged MccC7-C51* did not lead to any loss
of 44 u (Figure 5).
Negative-ion fragmentations of peptides are often as
informative as those generated in positive-ion mode
[33]. Here, negative-ion mode fragmentations revealed
information complementary to those arising from the
positive-ion mode, which allowed mainly the character-
ization of the peptide moiety. The loss of the threonine
side chain, which corresponds to a loss of 44 u, was
favored, while the loss of CO2 from the aspartic acid
residue was hindered.
Conclusions
ESI/MS has been used extensively for the characteriza-
tion of peptides and biomolecules. Here we show that
CID experiments constitute a method of choice to
investigate the structure of nucleotide peptides, and
that the fragmentation patterns strongly rely on the
charge state and charge location. This study shows that
both the positive- and negative-ion modes are essential
for a complete characterization of such compounds. The
complementary studies on PepC7-C51 and MccC7-C51*
allowed the interpretation of certain fragmentation
pathways of MccC7-C51. The analysis of MccC7-C51
and its two isolated independent regions in positive-
and negative-ion modes provided structural informa-
tion on both the nucleotide and the peptide moieties.
Ion-neutral complexes were used to rationalize the
fragmentations. Zwitterionic forms appeared to be fa-
vored in the gas phase because both basic and acid sites
were present [25]. Such zwitterionic species strongly
influence the orientation of the fragmentation pathways
and, in particular, the hindrance of the CO2 release,
Scwhich consequently induces the release of the threonineside chain. The mass accuracy provided by the LTQ
Orbitrap instrument was a key condition for a compre-
hensive interpretation of the fragmentation patterns.
Acknowledgments
The authors thank the mass spectrometry platforms of the Mu-
seum national d’Histoire naturelle (MNHN) and the laboratory of
Chimie Structurale Organique et Biologique (LCSOB) for access to
the ESI-Qq-TOF and LTQ Orbitrap instruments, respectively. The
authors are grateful to the MNHN, Université Pierre et Marie
Curie (Paris VI) and the Centre National de la Recherche Scienti-
fique (CNRS) for financial support.
References
1. Jain, A. A.; Rajeswari, M. R. Binding Studies on Peptide-Oligonucleotide
Complex: Intercalation of Tryptophan in GC-Rich Region of c-myc
Gene. Biochim. Biophys. Acta 2003, 1622, 73–81.
2. Jensen, O. N.; Kulkarni, S.; Aldrich, J. V.; Barofsky, D. F. Characteriza-
tion of Peptide-Oligonucleotide Heteroconjugates by Mass Spectrome-
try. Nucleic Acids Res. 1996, 24, 3866–3872.
3. Kuhn-Holsken E.; Lenz, C.; Sander, B.; Lurhrmann, R.; Henning, U.
Complete MALDI-TOF MS Analysis of Cross-Linked Peptide-RNA
Oligonucleotides Derived from Nonlabeled UV-Irradiated Ribonucleo-
protein Particles. RNA 2005, 11, 1915–1930.
4. Lenz, C.; Kuhn-Holsken E.; Henning, U. Detection of Protein-RNA
Crosslinks by Nano-LC-ESI-MS/MS Using Precursor Ion Scanning and
Multiple Reaction Monitoring (MRM) Experiments. J. Am. Soc. Mass
Spectrom. 2007, 11, 869–881.
5. Boschenok, J.; Sheil, M. M. Electrospray Tandem Mass spectrometry of
Nucleotide. Mass Spectrom. 1996, 10, 144–149.
6. Lindh, I.; Hjelmqvist, L.; Bergman, T.; Sjovall, J.; Griffiths, W. J. De Novo
Sequencing of Proteolytic Peptides by a Combination of C-Terminal
Derivation and Nano-Electrospray/Collision-Induced Dissociation
Mass Spectrometry. J. Am. Soc. Mass Spectrom. 2000, 11, 673–686.
7. Bowie, J. H.; Brinkworth, C. S.; Dua, S. Collision-Induced Fragmenta-
tions of the (M  H)- Parent Anions of Underivatized Peptides: An Aid
to Structure Determination and Some Unusual Negative Ion Cleavages.
Mass Spectrom. Rev. 2002, 21, 87–107.
8. Harrison, A. G. Sequence-Specific Fragmentation of Deprotonated Pep-
tides Containing H or Alkyl Side Chains. J. Am. Soc. Mass Spectrom. 2001,
12, 1–13.
9. Chad, C. N.; Microcinloskey, J. A. Collision-Induced Dissociation of
Adenine. J. Am. Chem. 1992, 114, 3661–3668.
10. Fu, H. X.; L.Qiang, L.; Wang, J.; Xiao, H.; Zhao, Y. Electrospray
Ionization Mass Spectra of Amino Acid Phosphoramidates of Adeno-
sine. Rapid Commun. Mass Spectrom. 2000, 14, 1813–1822.
11. Bowen, R.D.; Williams, D. H. Unimolecular Reactions of Isolated
Organic Ions. The Importance of Ion–Dipole Interactions. J. Chem. Soc.
Chem. Commun. 1980, 823, 2752–2756.
12. Longevialle, P.; Botter, R. Evidence for Intramolecular Interaction
Between Ionic and Neutral Fragments in the Mass Spectrometer.
J. Chem. Soc. Chem. Commun. 1980, 17, 823–825.
13. Debrauwer, L.; Rathahao, E.; Jouanin, I.; Paris, A.; Clodic, G.; Molines,
H.; Convert, O.; Fournier, F.; Tabet, J. C. Investigation of the Regio- and
Stereo-Selectivity of Deoxyguanosine Linkage to Deuterated 2-Hy-
droxyestradiol by Using Liquid Chromatography/ESI-Ion Trap Mass
Spectrometry. J. Am. Soc. Mass Spectrom. 2003, 14, 364–372.
14. Cole, R. B.; Tabet, J. C.; Salles, C.; Jallageas, J. C.; Crouzet, J. Structural
“memory effects” influencing decompositions of glucose alkoxide an-
6ions produced from monoterpene glycoside isomers in tandem mass
spectrometry. Rapid Commun. Mass Spectrom. 1989, 3, 59–61.
1198 PETIT ET AL. J Am Soc Mass Spectrom 2008, 19, 1187–119815. Bowie, J. H. The Fragmentations of Even-Electron Organic Negative
Ions. Mass Spectrom. Rev. 1990, 9, 349–379.
16. Duquesne, S.; Destoumieux-Garzon, D.; Peduzzi, J.; Rebuffat, S. Micro-
cins, Gene-Encoded Antibacterial Peptides from Enterobacteria. Nat.
Prod. Rep. 2007, DOI:10.1039/paper no B516237H.
17. Guijarro, J. I.; Gonzalez-Pastor, J. E.; Baleux, F.; San Millan, J. L.; Castilla,
M. A.; Rico, M.; Moreno, F.; Delepierre, M. Chemical Structure and
Translation Inhibition Studies of the Antibiotic Microcin C7. J. Biol.
Chem. 1995, 270, 23520–23532.
18. Metlitskaya, A.; Kazakov, T.; Kommer, A.; Pavlova, O.; Praetorius-Ibba,
M.; Ibba, M.; Krasheninnikov, I.; Kolb, V.; Khmel, I.; Severinov, K.
Aspartyl-tRNA Synthetase is the Target of Peptide Nucleotide Antibi-
otic Microcin C. J. Biol. Chem. 2006, 281, 18033–18042.
19. Duquesne, S.; Petit, V.; Peduzzi, J.; Rebuffat, S. Structural and Func-
tional Diversity of Microcins, Gene Encoded Antibacterial Peptide from
Enterobacteriaceae. J. Mol. Microbiol. Biotechnol. 2007, 13, 200–209.
20. Makarov, A. Electrostatic Axially Harmonic Orbital Trapping: A high-
Performance Technique of Mass Analysis. Anal. Chem. 2000, 72, 1156–
1162.
21. Hardman, M.; Makarov, A. A. Interfacing the Orbitrap Mass Analyzer
to an Electrospray Ion Source. Anal. Chem. 2003, 75, 1699–1705.
22. Hu, Q.; Noll, R. J.; Li, H.; Makarov, A.; Hardman, M.; Graham Cooks, R.
The Orbitrap: A New Mass Spectrometer. J. Mass Spectrom. 2005, 40,
430–443.
23. Makarov, A. D.; E.Lange, O.; Horning, S. Dynamic Range of Mass
Accuracy in LTQ Orbitrap Hybrid Mass Spectrometer. J. Am. Soc. Mass
Spectrom. 2006, 17, 977–982.
24. Peterman, S. M.; Duczak, N., . Jr.; Kalgutkar, A. S.; Lame, M. E.; Soglia,
J. R. Application of a Linear Ion Trap/Orbitrap Mass Spectrometer in
Metabolite Characterization Studies: Examination of the Human Liver
Microsomal Metabolism of the Nontricyclic Antidepressant Nefaz-odone Using Data-Dependent Accurate Mass Measurements. J. Am. Soc.
Mass Spectrom. 2006, 17, 363–375.
25. Nordhoff, E. K.; F; .Roepstorff, P. Mass Spectrometry of Nucleic Acids.
Mass Spectrom. Rev. 1996, 15, 67–138.
26. Fournier, F.; Remaud, B.; Blasco, T.; Tabet, J. C. Ion–dipole Complex
Formation from Deprotonated Phenol Fatty Acid Esters Evidenced by
Using Gas-Phase Labeling Combined with TandemMass Spectrometry.
J. Am. Soc. Mass Spectrom. 1993, 4, 343–351.
27. Madalinski, G.; Fournier, F.; Wind, F. L.; Afonso, C.; Tabet, J. C.
Gram-Negative Bacterial Lipid A Analysis by Negative Electrospray
Ion Trap Mass Spectrometry: Stepwise Dissociations of Deprotonated
Species Under Low Energy CID Conditions. Int. J. Mass Sepctrom. 2006,
249/250, 77–92.
28. Sleno, L.; Volmer, D. A. Ion Activation Methods for Tandem Mass
Spectrometry. J. Mass Spectrom. 2004, 39, 1091–1112.
29. Roepstorff, P.; Fohlman, J. Proposal for a Common Nomenclature for
Sequence Ions in Mass Spectra of Peptides. Biomed. Mass Spectrom. 1984,
11, 601.
30. Biemann, K. Appendix 5. Nomenclature for Peptide Fragment Ions
(Positive Ions). Methods Enzymol. 1990, 886–887.
31. Bunk, D. M.; Macfarlane, R. D. Fragmentation of Proteins in the 13- to
29-kDa Mass Range Observed by 252Cf-Plasma Desorption Mass Spec-
trometry. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 6215–6219.
32. Dongré, A. R.; Jones, J. L.; Somogyi, A.; Wysocki, V. H. Influence of
Peptide Composition, Gas-Phase Basicity, and Chemical Modification
on Fragmentation Efficiency: Evidence for the Mobile Proton Model.
J. Am. Chem. Soc. 1996, 118, 8365–8374.
33. Steinborner, S. T.; Bowie, J. H. The Negative Ion Mass Spectra of [M 
H]–Ions Derived from Caeridin and Dynastin Peptides. Internal Back-
bone Cleavages Directed through Asp and Asn Residues. Rapid Com-
mun. Mass Spectrom. 1997, 11, 253–258.
